Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes.

Frederick NM, Shah PV, Didonna A, Langley MR, Kanthasamy AG, Opal P.

Hum Mol Genet. 2018 Dec 26. doi: 10.1093/hmg/ddy433. [Epub ahead of print]

PMID:
30590536
2.

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.

Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM.

CNS Spectr. 2018 Dec;23(6):402-413. doi: 10.1017/S1092852918001359.

PMID:
30588905
3.

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T; Parkinson's Progression Markers Initiative.

Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477. doi: 10.1002/acn3.644. eCollection 2018 Dec.

4.

Self-reported physical activity levels and clinical progression in early Parkinson's disease.

Amara AW, Chahine L, Seedorff N, Caspell-Garcia CJ, Coffey C, Simuni T; Parkinson's Progression Markers Initiative.

Parkinsonism Relat Disord. 2018 Dec 10. pii: S1353-8020(18)30487-5. doi: 10.1016/j.parkreldis.2018.11.006. [Epub ahead of print]

PMID:
30554993
5.

New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics.

Sardi SP, Simuni T.

Parkinsonism Relat Disord. 2018 Oct 23. pii: S1353-8020(18)30460-7. doi: 10.1016/j.parkreldis.2018.10.025. [Epub ahead of print]

PMID:
30391183
6.

Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.

Burack M, Aldred J, Zadikoff C, Vanagunas A, Klos K, Bilir B, Fernandez HH, Standaert DG.

Mov Disord Clin Pract. 2018 Jun 27;5(4):383-393. doi: 10.1002/mdc3.12630. eCollection 2018 Jul-Aug. Review.

PMID:
30363427
7.

Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer.

Murmann AE, Yu J, Opal P, Peter ME.

Trends Cancer. 2018 Oct;4(10):684-700. doi: 10.1016/j.trecan.2018.08.004. Epub 2018 Sep 26. Review.

PMID:
30292352
8.

"Dance Therapy" as a psychotherapeutic movement intervention in Parkinson's disease.

Michels K, Dubaz O, Hornthal E, Bega D.

Complement Ther Med. 2018 Oct;40:248-252. doi: 10.1016/j.ctim.2018.07.005. Epub 2018 Jul 7.

PMID:
30219460
9.

Acupuncture as Adjuvant Therapy for the Management of Cervical Dystonia.

Bega D, Park K, Grimone A, Lin F, Ring M.

Med Acupunct. 2018 Aug 1;30(4):198-203. doi: 10.1089/acu.2018.1291.

10.

Cognition among individuals along a spectrum of increased risk for Parkinson's disease.

Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub D; Parkinson’s Progression Markers Initiative.

PLoS One. 2018 Aug 20;13(8):e0201964. doi: 10.1371/journal.pone.0201964. eCollection 2018.

11.

Predictors of clinically meaningful change in PDQ-39 in Parkinson's disease.

Margolius A, Cubillos F, He Y, Wu S, Schmidt P, Simuni T; NPF QII Investigators.

Parkinsonism Relat Disord. 2018 Nov;56:93-97. doi: 10.1016/j.parkreldis.2018.06.034. Epub 2018 Jul 2.

PMID:
30056039
12.

Altered resting-state functional connectivity of the putamen and internal globus pallidus is related to speech impairment in Parkinson's disease.

Manes JL, Tjaden K, Parrish T, Simuni T, Roberts A, Greenlee JD, Corcos DM, Kurani AS.

Brain Behav. 2018 Sep;8(9):e01073. doi: 10.1002/brb3.1073. Epub 2018 Jul 25.

13.

Acute Stroke in Middle Cerebellar Peduncle in a Patient With FXTAS.

Hall DA, Fraint A, Dafer R.

Front Genet. 2018 May 25;9:187. doi: 10.3389/fgene.2018.00187. eCollection 2018.

14.

DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.

Yomtoob J, Koloms K, Bega D.

Parkinsonism Relat Disord. 2018 Aug;53:37-41. doi: 10.1016/j.parkreldis.2018.04.037. Epub 2018 May 5.

PMID:
29748111
15.

Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD.

Xie T, Bloom L, Padmanaban M, Bertacchi B, Kang W, MacCracken E, Dachman A, Vigil J, Satzer D, Zadikoff C, Markopoulou K, Warnke P, Kang UJ.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):989-994. doi: 10.1136/jnnp-2018-318060. Epub 2018 Apr 13.

PMID:
29654112
16.

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.

Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K; Parkinson's Progression Marker Initiative*.

Mov Disord. 2018 May;33(5):771-782. doi: 10.1002/mds.27361. Epub 2018 Mar 23.

17.

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.

Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ.

Mov Disord. 2018 Jul;33(6):928-936. doi: 10.1002/mds.27338. Epub 2018 Mar 23.

PMID:
29570853
18.

Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1.

Edamakanti CR, Do J, Didonna A, Martina M, Opal P.

J Clin Invest. 2018 Jun 1;128(6):2252-2265. doi: 10.1172/JCI96765. Epub 2018 Apr 23.

19.

ANP32A regulates histone H3 acetylation and promotes leukemogenesis.

Yang X, Lu B, Sun X, Han C, Fu C, Xu K, Wang M, Li D, Chen Z, Opal P, Wen Q, Crispino JD, Wang QF, Huang Z.

Leukemia. 2018 Jul;32(7):1587-1597. doi: 10.1038/s41375-018-0010-7. Epub 2018 Feb 2.

PMID:
29467488
20.

The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?

Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K, Fernandez HH, Stocchi F.

Parkinsonism Relat Disord. 2018 Jun;51:9-16. doi: 10.1016/j.parkreldis.2018.02.001. Epub 2018 Feb 2. Review.

PMID:
29456046

Supplemental Content

Loading ...
Support Center